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A putative collagen structure from macrophage scavenger eceptors binds to a wade range of ligands. In order to elucidate the ligand’s binding 
mode, this collagen structure was constructed using short peptides. This was accomplished by the reaction of a tri-bromoacetylated branched peptide 
with a purified unprotected 25-residue peptide, which contained Cys, 4 repeats of the triplet, Gly-Pro-Hyp, and 12 residues from the bovine 
macrophage scavenger receptor (residues 332 to 343). The three identical 25-residue peptides are linked at the N-terminus. CD and NMR spectra 
of the N-terminus cross-linked tripeptide show that it forms a collagen structure below 10°C and an extended structure at high temperature with 
a midpoint of 20°C. 
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1. INTRODUCTION 
The bovine macrophage scavenger eceptor is known 
to play a key part in atherogenesis. It has two types of 
structures (Type I and II) and they have been found to 
consist of 453 and 349 amino acids, respectively, as 
deduced from their nucleotide sequences [1,2]. They 
exist in a trimerized form and the trimerization is re- 
quired for their function. They possess one membrane- 
spanning region (26 amino acids) and their N-terminal 
50 amino acids lie in the cytoplasm with their C-termi- 
nus outside. The external region of both receptors is 
divided into four regions; a spacer domain (32 amino 
acids), an a-helical coiled-coil domain (163 amino 
acids), a collagen-like domain (72 amino acids), and a 
C-terminal type-specific domain (110 for Type I and 6 
amino acids for Type II). The uptake of acetyl-LDL and 
oxidized LDL by the scavenger eceptors is initiated by 
their binding to the C-terminal part of the collagen-like 
domain. Four Lys residues at position 327,334,337 and 
340 in the receptor have been revealed to be responsible 
for the substrate binding, with Lys-337 as the most 
crucial [3]. The receptor binds not only acetyl or oxi- 
dized-LDL but also a variety of ligands such as maleyl- 
ated BSA, polyvinyl sulfate and polyinosine (poly(1)) 
[4]. On the other hand, LDL, BSA and poly(C) do not 
bind. In order to elucidate the binding mode of the 
receptor and its substrates, it is most suitable to prepare 
the collagen structure using a short peptide. Collagen 
structures have been previously synthesized by using 
short peptides, three of which were linked at the C- 
terminus. These peptides have been chemically synthe- 
sized from the C-terminus to the N-terminus by either 
stepwise or block condensation [5,6]. However, this ap- 
proach may lead to certain difficulties in the isolation 
step, since synthetic peptides contain mixtures of trun- 
cated peptides. We report an alternative method for 
preparing an N-terminus cross-linked tripeptide. The 
collagen-like structure of the peptide was analyzed by 
CD and NMR spectroscopy. 
2. MATERIALS AND METHODS 
*Corresponding author. Fax: (81) (6) 872 8210. 2.1. Synthesis of a 25_residuepeptide, C(GPHyp),GQKGQKGEKGS- 
GNH,, I 
Abbreviations: LDL, low density lipoprotein; BSA, bovine serum al- 
bumin; Fmoc, 9-fluorenylmethoxycarbonyl; Hyp, hydroxyproline; 
tBu, t-butyl; tBoc, t-butoxycarbonyl; Trt, trityl; BrZ, 2-bromoben- 
zyloxycarbonyl; mBHA resin, 4-methyl benzhydrylamine resin; 
HPLC, high pressure liquid chromatography; NMP, N-meth- 
ylpyrrolidone; TFA, trifluoroacetic acid; TFMSA, trifluoromethane- 
sulfonic acid; DCC, dicyclohexylcarbodiimide; HOBt, hydroxyben- 
zotriazole. 
The peptide was synthesized by standard protocols using 9-fluoren- 
ylmethoxycarbonyl (Fmoc) chemistry on a 4-(2’,4’-dimethoxyphenyl- 
Fmoc-aminomethyl)-phenoxy resin in an Applied Biosystems peptide 
synthesizer, Model 430A. The side chain protecting groups used are 
tBu for Ser and Hyp, tBoc for Lys, OtBu for Glu, and Trt for Cys. 
After cleavage from the resin by treatment with TFA containing 5% 
ethanedithiol and anisole (1:3, v/v) for 1.5 h, the crude peptide was 
precipitated by addition of cold ether. The precipitate was dissolved 
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in aqueous acetic acid and purified by preparative reversed-phase 
HPLC on an Aquapore Prep 10 (C-8,300 A pore size, Applied Biosys- 
terns) with 0.1% TFA in a water/acetonitrile gradient. The amino acid 
sequence was confirmed by automated Edman degradation on an 
Applied Biosystems Model 477A. The purified peptide was hydro- 
lyzed in a saturated 6 N HCl atmosphere at 150°C for 1 h using a 
Waters PICO-TAG Work Station, and amino acid analysis was per- 
formed on a Beckman Mode6300 amino acid analyzer. Amino acid 
analysis (expected value in parentheses), Cys 0.7 (I), Gly 9 (9) Pro 3.9 
(4), Hyp 4.1 (4), Glmu 3.3 (3), Lys 3.2 (3), Ser 1.1 (1). FAB mass 
spectra, m/z = 2331.2, (M+H)‘. Calcd. for C,,H,,,N,,O+& = 2331.1 
2.2. Synthesis of a tri-N-bromoacetylated branched peptide. 2 
Using 4-methyl benzhydrylamine (MBHA) resin, Tyr, Gly, Lys, and 
Lys were condensed stepwise in the peptide synthesizer using Fmoc 
chemistry. The protecting groups of the side chain were BrZ for Tyr 
and tBoc for Lys. After the tetrapeptide was synthesized, the Fmoc 
group was removed by 20% piperidine in NMP for 20 min and the 
tBoc group was removed by 50% TFA in CH,Cl, for 20 min followed 
by neutralization with 5% diisopropylethylamine in NMP. Fmoc-/I- 
Ala and bromoacetic acid were then condensed stepwise to the peptide 
resin in the peptide synthesizer. Completion of each of the reactions 
was monitored by the ninhydrin test [7]. The peptide resin was treated 
with a mixture of TFA, m-cresol and TFMSA (9:1:1, v/v) for 1 h at 
room temperature. Subsequently, water was added to the mixture with 
cooling and the mixture was washed with n-pentane twice followed by 
ether twice. The aqueous solution was applied to reversed phase 
HPLC (Vydac C-4, 300 A, 5 ,um, 4.6 x 150 mm) and the fractions 
containing the desired branched peptide were pooled and then lyophil- 
ized. FAB mass spectra m/z = 1067.0, (M+H)‘. Calcd. for 
&H,,N,,O,,Br, = 1067.2 
2.3. Synthesis of an N-terminus cross linked tripeptide, 3 
The 25-residue peptide, 1, (5 pmol) and the branched peptide, 2, (1.4 
pmol) were mixed in 0.1 M NaHCO, and 3 M GdnHCl solution (2 
ml). After 6 h at room temperature, pH of the mixture was adjusted 
to approximately 2 by addition of TFA and the mixture was applied 
to reversed-phase HPLC. The branched peptide was eluted by a linear 
gradient of CH,CN (10-258) containing 0.1% TFA at a flow rate of 
1 ml/min. The fractions containing the desired product were pooled 
and lyophilized. Amino acid analysis (expected value in parentheses), 
S-carboxymethyl cystein 3.2 (3) Gly 28 (28), Pro 11.9 (12), Hyp 12.1 
~l2),Gln/u9.5(9),Lysll.5(ll),Ser.3.l(3),Tyrl.5(l),~-Ala3.2(3). 
Ion-spray mass spectrum was measured on a triple quadruple mass 
spectrometer (SCIEX AP III, Canada) equipped with a standard at- 
mospheric pressure ionization source (Fig. 3). 
2.4. Cwcular dichroism (CD) measurement 
CD spectra were recorded at 4, 37 and 85°C on a J-600 spectropo- 
larimeter (Japan Spectroscope) with a l-mm path-length cuvette. The 
peptide was dissolved in 5 mM sodium phosphate at pH 7, at a 
concentration of 10 PM. A thermal transition curve was obtained by 
momtormg [@I,,, as a function of temperature with a 2-mm path- 
24mer 
BrCH$O-BAla 
I 
length cuvette. The peptide concentration was 100 PM, and the tem- 
perature was increased at a rate of l’C/min. 
2.5. Nuclear magnetic resonance (NMR) measurement 
Proton NMR spectra were recorded on a Bruker AM600 spectrom- 
eter. The peptide was dissolved in 5 mM sodium phosphate buffer at 
a concentration of 5 mg/ml (about 0.6 mM) at pH 7.2. Chemical shifts 
are expressed in ppm to 2,2-dimethyl-2-silapentane-5-sulfonate (DSS). 
3. RESULTS AND DISCUSSION 
The collagen structure exhibits scavenger eceptor li- 
gand binding. Due to its broad binding specificity, it is 
valuable to construct the essential collagen structure to 
elucidate its manner of binding to substrates. When 
evaluating the predicted structure of the scavenger e- 
ceptor, it is possible to predict that an a-helical coiled- 
coil domain is likely to fold first and the comformation 
propagates to the collagen domain [ 1,2]. Type II scaven- 
ger receptor, in particular, in the C-terminal type spe- 
cific domain, has only 6 amino acids (Ser-Met-Gln-Arg- 
Pro-Gly) which are not likely to form any secondary 
structures. The C-terminus domain is also not likely to 
be a nucleation center in forming the tertiary structure 
of the scavenger eceptor. The six amino acid residues 
are not involved in the substrate binding [3]. To date, 
a number of chemical syntheses of collagen have been 
reported. The collagen is usually synthesized from the 
C- to N-terminus of the n-i-branched peptide. However, 
although a peptide covalently cross-linked at the N- 
terminus has also been reported, this peptide contains 
only Pro, Ala and Gly, which have no functional groups 
in the side chains [8]. 
In order to generate the collagen structure of the 
scavenger receptor more precisely, the N-terminus, 
rather than the C-terminus, of the peptide should be 
covalently cross linked to form the collagen structure. 
Recent advances allow peptides with chain lengths of 
approximately 30 to be synthesized with high purity by 
conventional automated peptide synthesizers. Our strat- 
egy, therefore, is based on an initial purification of the 
unprotected peptide, followed by cross-linking at the 
N-terminus to induce trimerization. Selective reaction 
of an N-bromoacetyl derivative and sulfhydryl group of 
Cys is reported to produce the peptide-protein conju- 
NH, 
v$Gt?H-CH$-CH$O-PAla 
C N ,2 I 
3 Cys 41 BrCH&O-PAla -Lys-Lys-Gly-Tyr,,2j + 
N C I 
~~COCH-CH~-CH~O-~Ala-Lys-Lys-Gly-Tyr~H2 
NH2 I 
BrCH&O-BAla Fb C&H-CH$-CHFO-BAla 
1 - 2 - 
Fig. 1. Synthetic protocol of the N-terminus crosslinked tripeptide as a collagen model. 
(GPH~~),GQKGQKGEKGSGNH,. 
2 
The open box indicates the 24-residue peptide, 
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gate or cyclic peptide [9]. Here, three identical peptide 
chains with Cys at the N-terminus are coupled to a 
tri-N-bromoacetylated branched peptide, as shown in 
Fig. 1. 
We first synthesized a 25-residue peptide, 1. It con- 
tains 12 amino acids (Gly-Gln-Lys-Gly-Gln-Lys-Gly- 
Glu-Lys-Gly-Ser-Gly) corresponding to the C-terminus 
(332 to 343) of the predicted collagen structure of the 
bovine scavenger eceptor and four repeats of a tripep- 
tide, Gly-Pro-Hyp, and Cys, at the N-terminus. Tripep- 
tide, Gly-Pro-Hyp, has a strong tendency to form a 
collagen structure and therefore can stabilize the colla- 
gen structure [lo]. Cys is used to covalently cross-link 
at the N-terminus. Though the 12 amino acid residues 
may be insufficient for biological assay since one Lys at 
327 is omitted, our initial approach is to synthesize the 
collagen structure to evaluate the utility of synthetic 
method. The peptide, 1. was synthesized using an auto- 
mated peptide synthesizer and purified by reversed 
phase HPLC. The structure was confirmed by amino 
acid analysis, peptide sequence analysis and FAB-mass 
analysis. 
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Fig. 2. HPLC analysis of the reaction mixture of 1 and 2 at (a) t = 0 
and (b) t = 6 h. I, the 25 residue peptide, 1; II, tri-N-bromoacetylated 
branched peptide, 2; III, cross linked tripeptide, 3; IV, dimerized 1. 
Chromatography was carried out on a TSKgel ODS-12OT (4.6 
mm x 22 cm, TOSOH) at a flow rate of 1 mUmin with a linear gradient 
of CH,CN (&50%) for 30 mm in 0.1% TFA. 
Synthesis of the tri-N-bromoacetylated branched 
peptide was carried out as follows. On MBHA resin, 
Tyr was attached for quantitation. A BrZ group was 
used for Tyr side chain protection since this group is 
stable under the TFA treatment conditions required for 
side chain deprotection of Lys, but removed by treat- 
ment with TFMSA. After condensation of Fmoc-Gly as 
a spacer, two Fmoc-Lys(tBoc) were condensed. The 
Fmoc and tBoc groups were removed by piperidine and 
TFA, respectively. The NE-amino and two N&-amino 
groups of Lys in Lys-Lys-Gly-Tyr(BrZ)-MBHA resin 
were condensed with Fmoc#-Ala and bromoacetic acid 
activated by DCC and HOBt. The peptide resin was 
treated with a mixture of TFA, m-cresol and TFMSA 
for 1 h. The peptide did not precipitate in ether. The 
mixture was washed with n-pentane and ether and then 
2 was isolated by reversed phase HPLC. The structure 
of 2 was confirmed by FAB-mass analysis. 
After the reaction of the 25-residue peptide, 1, and the 
tri-llibromoacetylate branched peptide, 2, for 6 h in 3 
M GdnHCl at pH 7.5, the desired product, 3, identified 
as the main product by monitoring of the reaction by 
means of reversed phase HPLC (Fig. 2). The product 
was isolated at a 70% yield. The structure of 3 was 
confirmed by amino acid analysis. Ion spray mass spec- 
trometry indicated that the average mass was 
7822.2 f 0.4 (calculated MW, 7821.7 Da for 
Cj,,H,i,NrO@&) (Fig. 3). 
Formation of the collagen structure was analyzed by 
CD spectra (Fig. 4). CD spectra of the peptide at 4°C 
and pH7 showed a positive band around 223 nm and 
a minimum band around 198 nm, indicating that the 
peptide formed a collagen structure. At 37°C for biolog- 
ical assay, the minimum at 198 nm in the CD spectrum 
shifted to 202 nm with a decreased magnitude, showing 
the melting of the triple helix. The thermal transition 
curve was obtained by monitoring [0]223 as a function 
of temperature. It exhibited a sharp thermal transition 
with a midpoint of 20°C. 
NMR spectra in D,O of the collagen structure of the 
peptide with the amino acid sequence (Pro-Hyp-Gly),, 
showed amido protons of Gly at around 8 ppm [l 11. The 
N-terminus cross linked tripeptide, 3, synthesized here, 
also had amido protons around 8ppm (Fig. 5). This 
peak remains even after 2 days at 4’C, indicating the 
peptide has a relatively stable structure. The amido pro- 
ton signal decreases as the temperature increases finally 
disappearing at 20°C due to a rapid H-D exchange. 
This result is consistent with that obtained from CD 
spectra. It also suggests that the peptide forms a colla- 
gen structure. 
In conclusion, this N-terminus cross linked tripeptide 
could be easily synthesized and purified by condensa- 
tion with an unprotected purified peptide which has Cys 
at the N-terminus and a tri-N-bromoacetylated 
branched peptide. The synthesized peptide forms a col- 
lagen structure below 10°C, but unfolds at 25°C. For 
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Fig. 3. The ion-spray mass spectrum of the cross-linked tripeptide, 3. From each m/z value of the multiply charged ion signals ([M+nH]“‘), the 
molecular weight of 3 was calculated to be 7822.2 It 0.4. 
biological assay, one should make a stable collagen 
structure at 37°C. One way to do this is to increase the 
number of the tripeptide, Gly-Pro-Hyp. An other way 
is to elongate the amino acid sequence of the scavenger 
receptor so as to contain the 4 Lys residues responsible 
for full activity. 
This synthesis can be done in the presence of 
GdnHCl, suggesting that a secondary structure, which 
sometimes leads to difficulties during the condensation 
reaction, is not formed during the reaction. This method 
is, therefore, useful for not only construction of collagen 
structures, but also for synthesis of 4-helical bundle 
proteins [12,13]. 
a) 
Wavelength [nm] 
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